Security key
58471K111
Medicus Pharma Ltd. - *W EXP 11/15/202 (MDCXW)
CUSIP: 58471K111
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / *W EXP 11/15/202
- Total 13F shares
- 111,203
- Total 13F value
- $63,645
- Share change
- -60,362
- SEC-reported price per share
- $0.65
- Number of holders
- 4
- Value change
- -$38,459
- Number of buys
- 1
- Number of sells
- 2
Report period
Q2 2026
Institutions
4
Top holders
4
MDCXW full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Medicus Pharma Ltd. SEC filings
Medicus Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 58471K111
Recent filing periods:
Ownership snapshot
Top reported holders of MDCXW - Medicus Pharma Ltd. - *W EXP 11/15/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kenneth R. Melani
Disclosed value leader
VELOCITY FUND PARTNERS, LP
Comparable rows
4/15
Latest evidence
03 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 18%
11 rows are not safely comparable across share classes.
13D/G row: Kenneth R. Melani
Showing 1-6 of 15 holder rows.
Quick read
Kenneth R. Melani leads the comparable SEC ownership view at 18%.
4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kenneth R. Melani's linked filing trail.
Comparable ownership
Top 4
Kenneth R. Melani
18%
ARMISTICE CAPITAL, LLC
5%
John Jason Hathaway
4.5%
Ajay Raju
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kenneth R. Melani |
13D/G
3/4/5
Melani Kenneth R. · 10%+ Owner
|
18%
Reported 13D/G
· 30 Jun 2025
|
$9,843,685
3,248,741 shares
|
-$227,250 | 30 Jun 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
Reported 13D/G
· 30 Jun 2025
|
$2,835,244
935,724 shares
|
-$1,000,736 | 30 Jun 2025 |
| John Jason Hathaway |
13D/G
John Hathaway
|
4.5%
Reported 13D/G
· 30 Jun 2025
|
$2,426,885
800,952 shares
|
$0 | 30 Jun 2025 |
| Ajay Raju |
13D/G
3/4/5
Raju Ajay · Director
|
3.7%
Reported 13D/G
· 31 Mar 2026
|
$893,750
2,031,250 shares
|
+$13,750 | 31 Mar 2026 |
| VELOCITY FUND PARTNERS, LP |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$38,572,068
6,572,482 shares
mixed-class rows
|
— | 20 May 2025 |
| Interchange Capital Partners, LLC |
13F
Company
|
—
denominator unverified
|
$6,182,160
1,661,871 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
111,203
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
5
Q2 2026 holders
4
Holder diff
-1
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend